当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析 - 现金流量表

佐力药业

(300181)

  

流通市值:85.73亿  总市值:99.74亿
流通股本:6.03亿   总股本:7.01亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金779,131,564.292,959,189,378.882,139,564,083.671,495,325,281.98
  收到的税费返还--58,883,400.3137,770,840.31
  收到其他与经营活动有关的现金30,428,664.17152,165,017.4219,295,819.9316,341,929.46
  经营活动现金流入小计809,560,228.463,111,354,396.32,217,743,303.911,549,438,051.75
  购买商品、接受劳务支付的现金276,460,303.531,059,904,965.39682,246,126.71423,941,855.54
  支付给职工以及为职工支付的现金119,448,852.99337,131,765.04252,698,606.02177,779,413.92
  支付的各项税费100,545,503.52324,683,279.32251,242,645.53175,890,393.32
  支付其他与经营活动有关的现金233,098,122.06977,832,651.63765,554,483.93482,242,376.94
  经营活动现金流出小计729,552,782.12,699,552,661.381,951,741,862.191,259,854,039.72
  经营活动产生的现金流量净额80,007,446.36411,801,734.92266,001,441.72289,584,012.03
二、投资活动产生的现金流量:
  收回投资收到的现金-2,431,998--
  取得投资收益收到的现金--3,585,0003,585,000
  处置固定资产、无形资产和其他长期资产收回的现金净额9,279.43890,980.5856,600-
  处置子公司及其他营业单位收到的现金净额--2,431,9982,431,998
  投资活动现金流入小计9,279.433,322,978.586,073,5986,016,998
  购建固定资产、无形资产和其他长期资产支付的现金56,330,292.55287,143,322.97213,470,483.25149,921,435.32
  投资支付的现金47,500,000127,431,99820,000,00020,000,000
  取得子公司及其他营业单位支付的现金--2,431,9982,431,998
  支付其他与投资活动有关的现金--56,772.55-
  投资活动现金流出小计103,830,292.55414,575,320.97235,959,253.8172,353,433.32
  投资活动产生的现金流量净额-103,821,013.12-411,252,342.39-229,885,655.8-166,336,435.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,400,000---
  其中:子公司吸收少数股东投资收到的现金2,400,000---
  取得借款收到的现金237,601,154798,700,000681,100,000494,300,000
  收到其他与筹资活动有关的现金2,017,50085,195,75052,014,25046,000,750
  筹资活动现金流入小计242,018,654883,895,750733,114,250540,300,750
  偿还债务支付的现金164,900,000565,000,000447,400,000280,400,000
  分配股利、利润或偿付利息支付的现金2,801,155.12431,494,665.08424,770,686.16433,705,331.94
  其中:子公司支付给少数股东的股利、利润-7,600,0007,600,0007,600,000
  支付其他与筹资活动有关的现金3,225,305.84,609,959.064,024,115.132,090,531.93
  筹资活动现金流出小计170,926,460.921,001,104,624.14876,194,801.29716,195,863.87
  筹资活动产生的现金流量净额71,092,193.08-117,208,874.14-143,080,551.29-175,895,113.87
四、汇率变动对现金及现金等价物的影响-63.35-144.48-96.54-103.54
五、现金及现金等价物净增加额47,278,562.97-116,659,626.09-106,964,861.91-52,647,640.7
  加:期初现金及现金等价物余额658,895,427.05775,555,053.14775,555,053.14775,555,053.14
  期末现金及现金等价物余额706,173,990.02658,895,427.05668,590,191.23722,907,412.44
补充资料:
  净利润-642,436,652.8-379,193,091.62
  资产减值准备-17,355,747.39-11,119,072.67
  固定资产和投资性房地产折旧-71,494,323.73-34,039,687.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,494,323.73-34,039,687.05
  无形资产摊销-4,957,594.72-2,432,122.85
  长期待摊费用摊销-3,786,774.04-2,308,647.08
  处置固定资产、无形资产和其他长期资产的损失--591,239.16-0
  固定资产报废损失-1,700,354.83-23,166.08
  财务费用-14,428,179.92-6,664,453.44
  投资损失-1,700,643.23-1,339,602.32
  递延所得税--2,074,614.77--1,465,508.49
  其中:递延所得税资产减少--1,387,002.75--1,097,299.31
    递延所得税负债增加--687,612.02--368,209.18
  存货的减少--19,078,903.71-42,857,480.84
  经营性应收项目的减少--335,154,759.84--241,000,415.16
  经营性应付项目的增加--38,115,096.79-50,001,624.1
  其他-44,730,943.59--
  现金的期末余额-658,895,427.05-722,907,412.44
  减:现金的期初余额-775,555,053.14-775,555,053.14
  现金及现金等价物的净增加额--116,659,626.09--52,647,640.7
公告日期2026-04-272026-04-272025-10-282025-08-20
审计意见(境内)标准无保留意见
TOP↑